The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
- Author(s)
- Kelly, PN; Strasser, A;
- Details
- Publication Year 2011-09,Volume 18,Issue #9,Page 1414-1424
- Journal Title
- CELL DEATH AND DIFFERENTIATION
- Publication Type
- Journal Article
- Abstract
- Tumour development requires a combination of defects that allow nascent neoplastic cells to become self-sufficient for cell proliferation and insensitive to signals that normally restrain cell growth. Among the latter, evasion of programmed cell death (apoptosis) has proven to be critical for the development and sustained growth of many, perhaps all, cancers. Apoptotic cell death is regulated by complex interactions between pro-survival members and two subgroups of pro-apoptotic members of the B-cell lymphoma-2 (Bcl-2) protein family. In this invited review article, we reminisce on the discovery of Bcl-2, the first regulator of cell death identified, we discuss the mechanisms that control apoptotic cell death, focussing on how defects in this process promote the development and sustained growth of tumours and also affect their responses to anticancer therapeutics and, finally, we describe how current knowledge of the regulatory networks of apoptosis is exploited to develop novel approaches for cancer therapy. Cell Death and Differentiation (2011) 18, 1414-1424; doi:10.1038/cdd.2011.17; published online 18 March 2011
- Publisher
- NATURE PUBLISHING GROUP
- Keywords
- CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELL-LYMPHOMA; BH3-ONLY PROTEINS PUMA; BH3 MIMETIC ABT-737; MCL-1 UP-REGULATION; TRANSGENIC MICE; IN-VIVO; MEMBRANE PERMEABILIZATION; CHROMOSOME-TRANSLOCATION; INDUCED APOPTOSIS
- Publisher's Version
- https://doi.org/10.1038/cdd.2011.17
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2011-09-01 12:00:00